Kyle E. Allen, Ph.D. - Publications
Affiliations: | 2010 | University of Washington, Seattle, Seattle, WA |
Area:
Pharmacy, Physiology BiologyYear | Citation | Score | |||
---|---|---|---|---|---|
2007 | Totah RA, Allen KE, Sheffels P, Whittington D, Kharasch ED. Enantiomeric metabolic interactions and stereoselective human methadone metabolism. The Journal of Pharmacology and Experimental Therapeutics. 321: 389-99. PMID 17259447 DOI: 10.1124/Jpet.106.117580 | 0.526 | |||
2005 | Cameron MD, Wen B, Allen KE, Roberts AG, Schuman JT, Campbell AP, Kunze KL, Nelson SD. Cooperative binding of midazolam with testosterone and alpha-naphthoflavone within the CYP3A4 active site: a NMR T1 paramagnetic relaxation study. Biochemistry. 44: 14143-51. PMID 16245930 DOI: 10.1021/Bi051689T | 0.583 | |||
2004 | McConn DJ, Lin YS, Allen K, Kunze KL, Thummel KE. Differences in the inhibition of cytochromes P450 3A4 and 3A5 by metabolite-inhibitor complex-forming drugs. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 32: 1083-91. PMID 15377640 DOI: 10.1124/Dmd.32.10.1083 | 0.657 | |||
2004 | Isoherranen N, Kunze KL, Allen KE, Nelson WL, Thummel KE. Role of itraconazole metabolites in CYP3A4 inhibition. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 32: 1121-31. PMID 15242978 DOI: 10.1124/Dmd.104.000315 | 0.626 | |||
Show low-probability matches. |